Newsroom

News from UCLB

Subscribe To Our News Feed
BioMarin's valoctocogene roxaparvovec a Breakthrough Therapy for hemophilia A

BioMarin’s valoctocogene roxaparvovec a Breakthrough Therapy for hemophilia A

/ UCLB News
BioMarin today announced that the U.S. Food and Drug Administration (FDA) granted valoctocogene roxaparvovec (formally BMN 270) a Breakthrough Therapy ...
New licensing agreement for UCL technology to combat antimicrobial resistance

New licensing agreement for UCL technology to combat antimicrobial resistance

/ UCLB News
The alarming rise and spread of antimicrobial resistance is an increasing global challenge and there is considerable interest and an ...
Autolus secures US$80 million series C funding

Autolus secures US$80 million series C funding

/ Spinout News
Proceeds will be used to establish clinical proof of concept for three novel haematological cancer programs UCL Business spinout company, ...
Synthace raises £7.3m to accelerate biotechnology to enable faster breakthroughs

Synthace raises £7.3m to accelerate biotechnology to enable faster breakthroughs

/ Spinout News
• The Company’s Antha operating system brings end-to-end digitization to biotechnology, replacing current artisanal methods of development • Speaking from ...
Autolus announces initiation of the AMELIA and ALEXANDER studies for AUTO3: phase I/II studies in paediatric ALL and DLBCL

Autolus announces initiation of the AMELIA and ALEXANDER studies for AUTO3: phase I/II studies in paediatric ALL and DLBCL

/ Spinout News
AUTO3 is the first dual targeting CAR-T cell therapy to enter clinical studies targeting CD19 and CD22 with independently-acting CARs ...
Autolus announces first-dose cohort completed in APRIL study of AUTO2: a phase I/II study in patients with multiple myeloma

Autolus announces first-dose cohort completed in APRIL study of AUTO2: a phase I/II study in patients with multiple myeloma

/ Spinout News
AUTO2 is the first dual targeting CAR-T Cell therapy in clinical development for the treatment of multiple myeloma UCL Business ...
TC BioPharm announces CAR-T licensing deal with UCL Business

TC BioPharm announces CAR-T licensing deal with UCL Business

/ UCLB News
UCL academics will assist TCB with development of treatment for leukemia. Clinical programme will see first patients treated in 2018 ...
Measuring distance with a single photo

Measuring distance with a single photo

/ UCLB News
Most cameras just record colour but now the 3D shapes of objects, captured through only a single lens, can be ...
First patient treated in trial of a novel liver dialysis device, DIALIVE

First patient treated in trial of a novel liver dialysis device, DIALIVE

/ Spinout News
The first patient in an international trial of a new liver dialysis system has been recruited at the Royal Free ...
Chirp collaborates with Hijinx to bring toys to life

Chirp collaborates with Hijinx to bring toys to life

/ Spinout News
Chirp, a UCLB spinout company, has partnered with Chicago-based toy company Hijinx to create toys based on Netflix original series ...
On Tuesday 20th June 2017 UCLB hosted its annual summer reception

On Tuesday 20th June 2017 UCLB hosted its annual summer reception

/ Events
UCLB hosted its annual summer reception where guests enjoyed refreshing drinks and delicious canapés under UCL’s prestigious portico. UCLB’s Managing ...
UCL Business Award Winners 2017

UCL Business Award Winners 2017

/ Award Winners
Professor Michael Arthur, President & Provost of UCL, presented this year’s winners of the UCL Business Award at the UCLB ...
Cell and gene therapy catapult announces cell medica acquisition of WT1 T-cell therapy

Cell and gene therapy catapult announces cell medica acquisition of WT1 T-cell therapy

/ Spinout News
Acquisition transfers intellectual property and commercialisation rights to promising cancer immunotherapy Further development will take place at the Cell and ...
Helicon Health® receive funding from the SBRI

Helicon Health® receive funding from the SBRI

/ Spinout News
Helicon Health®, a UCL spinout company supported by UCL Business, has recently received funding from the Small Business Research Initiative ...
New eye test detects earliest signs of glaucoma

New eye test detects earliest signs of glaucoma

/ UCLB News
A SIMPLE eye test could help solve the biggest global cause of irreversible blindness, glaucoma. In clinical trials, the pioneering ...
UCL Technology Fund has approved investment of up to £1million in the development of gene therapy for p47-CGD

UCL Technology Fund has approved investment of up to £1million in the development of gene therapy for p47-CGD

/ Investment Opportunities
The UCL Technology Fund (UCLTF), which provides funding and support for UCL’s most transformative innovations, has approved an investment of ...
Annual Report 2016

Annual Report 2016

/ Annual Reports
Download the UCLB Annual Report 2016 as a pdf ...
Abzena plc and UCL Medical Research Council grant awarded to collaboration group developing novel autoimmune therapy

Abzena plc and UCL Medical Research Council grant awarded to collaboration group developing novel autoimmune therapy

/ Spinout News
Abzena plc (AIM: ABZA, ‘Abzena’ or the ‘Group’), a life sciences group providing services and technologies to enable the development ...
Funding of four initial projects and operational update

Funding of four initial projects and operational update

First four drug discovery programmes now launched in collaboration with academics at all three partner universities - spanning a variety ...
Antibody manufacturing development agreement signed with UCL

Antibody manufacturing development agreement signed with UCL

/ Spinout News
Abzena plc (AIM: ABZA, ‘Abzena’ or the ‘Group’), a life sciences group providing services and technologies to enable the development ...
Ocera announces top-line results for phase 2b study in hepatic encephalopathy

Ocera announces top-line results for phase 2b study in hepatic encephalopathy

/ Spinout News
Ocera Therapeutics, Inc. announces top-line results from its exploratory STOP-HE Phase 2b Study evaluating the efficacy, safety and tolerability of intravenously ...
Intract Pharma and Finch Therapeutics announce collaboration to enable targeted delivery of microbial communities

Intract Pharma and Finch Therapeutics announce collaboration to enable targeted delivery of microbial communities

/ Spinout News
Intract Pharma, an oral drug delivery spinout company from UCL School of Pharmacy and Finch Therapeutics, Inc., a microbiome therapeutics ...
UCL Technology Fund invests £1m in to School of Pharmacy project to treat pancreatic cancer

UCL Technology Fund invests £1m in to School of Pharmacy project to treat pancreatic cancer

/ Investment Opportunities
The UCL Technology Fund (UCLTF), which provides funding and support for UCL’s most transformative innovations, has approved an investment of ...
Glaucoma drug may have potential to treat Alzheimer’s disease

Glaucoma drug may have potential to treat Alzheimer’s disease

/ UCLB News
A drug which is used to treat the common eye disease glaucoma may have potential as a treatment for Alzheimer’s ...
New solution for making 2D nanomaterials

New solution for making 2D nanomaterials

/ UCLB News
Two-dimensional (2D) nanomaterials have been made by dissolving layered materials in liquids, according to new UCL-led research. The liquids can ...
The new Domainex Medicines Research Centre is opened by Sir Simon Campbell

The new Domainex Medicines Research Centre is opened by Sir Simon Campbell

/ Spinout News, UCLB News
Sir Simon Campbell CBE FRS FMedSci was welcomed by staff, and guests when he officially opened The Domainex Medicines Research ...
Yaqrit in The Sunday Times for breakthrough liver treatment

Yaqrit in The Sunday Times for breakthrough liver treatment

/ Spinout News
A breakthrough treatment for liver disease could offer hope to the millions worldwide who suffer from the illness and reduce ...
RAFT™ 3D cell culture system enables corneal modelling for research into potential blindness cure

RAFT™ 3D cell culture system enables corneal modelling for research into potential blindness cure

/ UCLB News
During today’s Nature Webinar, Professor Julie Daniels of UCL Institute of Ophthalmology explained how her laboratory has successfully developed multilayer ...
UCLB spin-outs at heart of new £1 billion life sciences investment group

UCLB spin-outs at heart of new £1 billion life sciences investment group

/ Spinout News, UCLB News
UCLB spin-out companies will be at the heart of a new £1 billion life sciences company which has been created ...
Willis Re and SpatialKey® collaborate to bring EuroTempest data to insurers

Willis Re and SpatialKey® collaborate to bring EuroTempest data to insurers

/ Spinout News
Insurers now have an easy way to access, visualise, and analyse European windstorm data from UCLB spinout company EuroTempest, to ...
MediaGamma launches next generation artificial intelligence product set to reshape the ad tech market

MediaGamma launches next generation artificial intelligence product set to reshape the ad tech market

/ Spinout News
MediaGamma, a spinout from UCL’s Computer Science department, which is supported by UCL Business, has announced the launch of a ...
BBC report on Chirp Skylander deal

BBC report on Chirp Skylander deal

/ Spinout News, UCLB News
BBC technology correspondant Rory Cellan-Jones, reports on Chirp's new deal with Activision, one of the world's biggest games businesses. Activision is ...
Achilles Therapeutics launched with funds of £13.2 million to develop immunotherapies for cancer

Achilles Therapeutics launched with funds of £13.2 million to develop immunotherapies for cancer

/ Spinout News, UCLB News
SYNCONA LLP and CANCER RESEARCH TECHNOLOGY (CRT) announce the formation of Achilles Therapeutics Ltd today. The new private company will ...
SmartTarget Ltd launches a device for the detection of prostate cancer

SmartTarget Ltd launches a device for the detection of prostate cancer

/ Spinout News, UCLB News
UCLB spinout SmartTarget Ltd announces the launch of a new device for the detection of prostate cancer. The CE certified ...
UCL receives largest share of NHS research funding

UCL receives largest share of NHS research funding

/ UCLB News
UCL’s three biomedical research centres (BRCs) have won more than £167 million in funding from the National Institute for Health ...
Cell Medica and UCL collaborate to develop modified T cell receptor products for the treatment of cancer

Cell Medica and UCL collaborate to develop modified T cell receptor products for the treatment of cancer

/ UCLB News
Cell Medica, a leader in developing, marketing and manufacturing cellular therapeutics for cancer and infections, has signed a research collaboration ...
Eye test may detect Parkinson’s before symptoms appear

Eye test may detect Parkinson’s before symptoms appear

/ UCLB News
A new low-cost and non-invasive eye test could detect Parkinson’s disease before symptoms including tremors and muscle stiffness develop, according ...
Endomag and Devicor Medical Products announce new distribution agreement expanding cancer patients' access to care

Endomag and Devicor Medical Products announce new distribution agreement expanding cancer patients’ access to care

/ Spinout News
Endomagnetics Ltd (Endomag), the cancer healthcare spinout company from UCL, and Devicor Medical Products, a division of Leica Biosystems, are ...
Alcohol abuse drug can be repurposed to treat a blinding disorder

Alcohol abuse drug can be repurposed to treat a blinding disorder

/ UCLB News
Disulfiram prevents scars forming in a mouse model of scarring conjunctivitis Human scar-making cells, from patients with scarring conjunctivitis, are ...
Santen and University College London to collaborate on  ophthalmic research and education

Santen and University College London to collaborate on ophthalmic research and education

/ Spinout News, UCLB News
Santen Pharmaceutical Co., Ltd. (Santen) and UCL (University College London) today announced that we have signed a Memorandum of Understanding ...
BioMarin provides positive data for BMN 270 gene therapy in haemophilia A

BioMarin provides positive data for BMN 270 gene therapy in haemophilia A

/ Spinout News
BioMarin Pharmaceutical Inc. presented positive interim data from an open-label phase 1/2 clinical trial of BMN 270, an investigational gene therapy ...
On Tuesday 12 July 2016 UCLB hosted its annual summer reception

On Tuesday 12 July 2016 UCLB hosted its annual summer reception

/ Events, UCLB News
The evening was set against the backdrop of the neo-classical UCL Portico and the Flaxman Gallery. The event provided an ...
UCL Business Award Winners 2016

UCL Business Award Winners 2016

/ Award Winners
Professor Geraint Rees, Dean of the Faculty of Life Sciences at UCL, who presented this years winners of the UCL Business ...
UCL Technology Fund makes £1 million investment in gene therapy company, Freeline Therapeutics

UCL Technology Fund makes £1 million investment in gene therapy company, Freeline Therapeutics

The UCL Technology Fund (‘UCLTF’), which is dedicated to investing in intellectual property commercialisation opportunities arising from UCL’s world-class research ...
Researchers at UCL have developed new software to improve the analysis of MRI scans, which will provide quicker and more accurate diagnosis of Alzheimer’s and other forms of dementia.

Researchers at UCL have developed new software to improve the analysis of MRI scans, which will provide quicker and more accurate diagnosis of Alzheimer’s and other forms of dementia.

/ Spinout News, UCLB News
Improved diagnosis will allow patients to receive earlier treatment for their symptoms, helping them live independently for longer. A prototype ...
Fortress Biotech presents positive data from phase 1/2 study

Fortress Biotech presents positive data from phase 1/2 study

/ UCLB News
Fortress Biotech has announced positive data from its phase I/II study of CNDO-109- activated allogeneic natural killercells  in acute myeloid leukemia (AML). Originally developed ...
Dr Martin Pule named BBSRC Most Promising Innovator

Dr Martin Pule named BBSRC Most Promising Innovator

/ Spinout News, UCLB News
Dr Martin Pule was last night named BBSRC Most Promising Innovator 2016 for his frontier innovations in T-cell medicine. The ...
UCLB spinout is awarded the Gartner Cool Vendor in Data Science 2016

UCLB spinout is awarded the Gartner Cool Vendor in Data Science 2016

/ Spinout News
Satalia, a UCLB spinout from the Department of Computer Science at UCL, is now a Gartner Cool Vendor in Data Science ...
Technology transfer: the leap to industry

Technology transfer: the leap to industry

/ UCLB News
Dr Steven Schooling Director of Physical Sciences, Engineering, Built Environment & Social Sciences at  UCLB explains some of the hurdles faced in commercialising ...
UCLB and F-Prime launch Orchard Therapeutics to treat rare childhood diseases

UCLB and F-Prime launch Orchard Therapeutics to treat rare childhood diseases

/ Spinout News, UCLB News
UCL Business PLC (“UCLB”), the technology transfer company of University College London (“UCL”), and F-Prime Capital Partners have launched Orchard ...
BioMarin provides encouraging preliminary data on first 8 patients in haemophilia A gene therapy program

BioMarin provides encouraging preliminary data on first 8 patients in haemophilia A gene therapy program

/ Spinout News, UCLB News
BioMarin Pharmaceutical Inc. have announced preliminary data from an ongoing Phase 1/2 clinical trial with BMN 270, an investigational gene ...
Cell and Gene Therapy Catapult, UCLB and Imperial Innovations announce positive interim review in ongoing AML WT1 T cell clinical trial

Cell and Gene Therapy Catapult, UCLB and Imperial Innovations announce positive interim review in ongoing AML WT1 T cell clinical trial

/ Spinout News, UCLB News
The Cell and Gene Therapy Catapult, the UK organisation dedicated to the growth of the UK cell and gene therapy industry ...
Annual Report 2015

Annual Report 2015

/ Annual Reports
Download the UCLB Annual Report 2015 as a pdf ...
Six new ventures join the Health Social Innovators Programme in London

Six new ventures join the Health Social Innovators Programme in London

/ Spinout News, UCLB News
The second cohort of social entrepreneurs tackling healthcare and wellbeing challenges in England have joined the accelerator in February 2016 ...
New DNA sequencing nanopore

New DNA sequencing nanopore

/ UCLB News
An exciting European collaboration between industry and academia has been announced to develop a new DNA sequencing nanopore pioneered from ...
Autolus Limited secures £40 million funding

Autolus Limited secures £40 million funding

/ Spinout News, UCLB News
UCLB spinout, Autolus Limited, a biopharmaceutical company focused on the development and commercialisation of next-generation engineered T-cell therapies for haematological ...
Albumedix announces exclusive commercialization agreement with ThioLogics for its proprietary drug conjugation platform

Albumedix announces exclusive commercialization agreement with ThioLogics for its proprietary drug conjugation platform

/ Spinout News
Combining ThioLogics' site-specific conjugation chemistry with Albumedix's drug delivery platform enables the creation of next-generation albumin drug conjugates Albumedix today ...
UCLB spinout Satalia backs optimisation research unit

UCLB spinout Satalia backs optimisation research unit

/ Spinout News, UCLB News
An exciting European collaboration between industry and academia has been announced as award-winning optimisation researchers of the Institute of Mathematics ...
Consortium of world-leading UK universities and global pharmaceutical companies launch £40 million fund to drive therapeutic innovation

Consortium of world-leading UK universities and global pharmaceutical companies launch £40 million fund to drive therapeutic innovation

/ Investment Opportunities, UCLB News
Unique collaboration between AstraZeneca, GlaxoSmithKline, Johnson & Johnson Innovation and the technology transfer offices of Imperial College London, UCL (University ...
UCL launches £50 million technology investment fund

UCL launches £50 million technology investment fund

/ Investment Opportunities, UCLB News
UCL (University College London) is today launching the UCL Technology Fund to invest £50 million in commercialising its world-leading research ...
UCL wins grant award to develop MS therapy from the U.S. National MS Society, Fast Forward group

UCL wins grant award to develop MS therapy from the U.S. National MS Society, Fast Forward group

/ UCLB News
Innovative work into multiple sclerosis (MS) and other neurodegenerative conditions has been recognized by the U.S. National MS Society through ...
UCLB launches Intract Pharma Ltd

UCLB launches Intract Pharma Ltd

/ Spinout News, UCLB News
UCL Business PLC (UCLB) is pleased to announce the creation of Intract Pharma Limited (“Intract”), a company specialising in the oral ...
UCLB spinout Abcodia announces its ROCA Test® for ovarian cancer screening which could reduce mortality rates by 20%

UCLB spinout Abcodia announces its ROCA Test® for ovarian cancer screening which could reduce mortality rates by 20%

/ Spinout News, UCLB News
UCL study shows ROCA Test® being developed by UCLB spinout Abcodia, which earlier in the year raised £5.25 million could be effective in reducing ...
Dowling – the real issues and the future

Dowling – the real issues and the future

/ UCLB News
The Technology Transfer Offices of Edinburgh, Imperial, Manchester, Oxford and UCL have collaborated to produce a briefing paper, "Dowling - ...
Yaqrit receives £2m investment to develop new treatments for liver disease

Yaqrit receives £2m investment to develop new treatments for liver disease

/ Spinout News, UCLB News
Yaqrit Limited (“Yaqrit”), a UK company specialising in interventions in liver disease, is pleased to announce that it has secured ...
Syncona and UCLB launch Freeline Therapeutics to develop gene therapies for bleeding disorders

Syncona and UCLB launch Freeline Therapeutics to develop gene therapies for bleeding disorders

/ Spinout News, UCLB News
Syncona LLP and UCL Business PLC (UCLB), the wholly-owned technology transfer company of UCL (University College London), announce the creation ...
UCL research reveals the secret to a painless life

UCL research reveals the secret to a painless life

/ UCLB News
People born with a rare genetic mutation are unable to feel pain, but previous attempts to recreate this effect with ...
Abcodia announces initial U.S. availability of the ROCA® test to aid in the early detection of ovarian cancer

Abcodia announces initial U.S. availability of the ROCA® test to aid in the early detection of ovarian cancer

/ Spinout News, UCLB News
Abcodia Ltd, a UCLB spinout company engaged in the commercial development of novel tests for the early detection of cancer, announced ...
Abzena announces private placement to raise £20m for acquisition

Abzena announces private placement to raise £20m for acquisition

/ Spinout News
Abzena plc, a life sciences company from UCL School of Pharmacy, providing services and technologies enabling the development and manufacture of ...
UCLB announces the launch of gene therapy company Athena Vision

UCLB announces the launch of gene therapy company Athena Vision

/ Spinout News, UCLB News
Athena Vision is focused on developing gene therapies for eye diseases based on research conducted at UCL UCL Business PLC, ...
New target for macular degeneration gets funding for clinical trials

New target for macular degeneration gets funding for clinical trials

/ UCLB News
The Medical Research Council is to fund researchers at the UCL Institute of Ophthalmology and Moorfields Eye Hospital to conduct ...
MediaGamma and 3D Repo pitch at EIE London

MediaGamma and 3D Repo pitch at EIE London

/ Spinout News
The successful Engage Invest Exploit (EIE) startup showcase came to London yesterday, supported for the first time by UCL Business ...
Helicon Health wins Design Council Award

Helicon Health wins Design Council Award

/ UCLB News
Helicon Health, a UCL spinout company supported by UCL Business PLC, has been named as a winner of the Design ...
UniQuest and UCLB team up on therapeutics collaborations

UniQuest and UCLB team up on therapeutics collaborations

/ Spinout News, UCLB News
A new international collaboration is set to uncover groundbreaking therapeutic-based discoveries and help progress them to the next crucial stage ...
Canbex Therapeutics announces start of phase II trial of VSN16R for spasticity

Canbex Therapeutics announces start of phase II trial of VSN16R for spasticity

/ Spinout News
Canbex Therapeutics Ltd today announced that its novel orally active medication for the treatment of spasticity, VSN16R, has entered a ...
Closed cell systems announces license agreement for the development and commercialization of new point-of-care cell processing system

Closed cell systems announces license agreement for the development and commercialization of new point-of-care cell processing system

/ UCLB News
- The license agreement includes access to a cell processing prototype developed by a consortium led by Lonza and University ...
FDA approves IMLYGIC™ developed by Biovex

FDA approves IMLYGIC™ developed by Biovex

/ Spinout News
The U.S. Food and Drug Administration (FDA) has approved the Biologics License Application for IMLYGIC™ (talimogene laherparepvec), a genetically modified ...
Puridify completes Series A funding round

Puridify completes Series A funding round

/ Spinout News
UCL spinout company, Puridify Limited, developers of novel bioprocessing purification technologies for industrial biomolecule manufacture, today announced the closing of ...
BioMarin enrols first patient in phase 1/2 trial of gene therapy drug for the treatment of haemophilia A

BioMarin enrols first patient in phase 1/2 trial of gene therapy drug for the treatment of haemophilia A

/ Spinout News, UCLB News
BioMarin Pharmaceutical Inc. announced today that it has enrolled the first patient in a Phase 1/2 trial for BMN 270, ...
First patient receives potential new treatment for wet age-related macular degeneration in London Project to Cure Blindness

First patient receives potential new treatment for wet age-related macular degeneration in London Project to Cure Blindness

/ UCLB News
A pioneering trial of a new treatment derived from stem cells for people with ‘wet’ age-related macular degeneration (AMD) has ...
Abzena acquire PacificGMP

Abzena acquire PacificGMP

/ Spinout News
Abzena plc (AIM: ABZA), the life sciences company from UCL School of Pharmacy, providing services and technologies to enable better biopharmaceutical ...
Health Social Innovators' Programme Open

Health Social Innovators’ Programme Open

/ Spinout News, UCLB News
UCL researchers and hospital staff with innovations that generate a social impact in healthcare are invited to apply to the ...
UCLB to co-host innovative ICT focused investment event in November 2015

UCLB to co-host innovative ICT focused investment event in November 2015

/ UCLB News
UCLB is pleased to announce its support for EIE London which will be taking place on the 18 November 2015 ...
Autifony raises further £8 million

Autifony raises further £8 million

/ Spinout News, UCLB News
Autifony Therapeutics Limited (Autifony), a company spun out from GSK to develop effective treatments for tinnitus and other hearing disorders, has ...
Dr Celia Caulcott has been appointed the next Vice-Provost (Enterprise)

Dr Celia Caulcott has been appointed the next Vice-Provost (Enterprise)

/ UCLB News
Dr Celia Caulcott has been appointed the next Vice-Provost (Enterprise) at UCL, with effect from 1 October 2015. The Office ...
Potential new approach to the treatment of systemic amyloidosis

Potential new approach to the treatment of systemic amyloidosis

/ Spinout News, UCLB News
Pentraxin Therapeutics Ltd announces publication of results, from first in human clinical trial. In 2009 GSK and Pentraxin Therapeutics Ltd, ...
3D Repo wins Canary Wharf Group’s Cognicity challenge

3D Repo wins Canary Wharf Group’s Cognicity challenge

/ Spinout News
3D Repo Ltd, a spinout of UCL Business PLC was this week announced as the winner of the Virtual Design ...
Double win for Spoonful of Sugar at Communiqué 2015

Double win for Spoonful of Sugar at Communiqué 2015

/ Spinout News
UCL School of Pharmacy spinout, Spoonful of Sugar picked up two top prizes at the Communiqué Awards 2015 in London ...
UCLB Annual Summer Reception

UCLB Annual Summer Reception

/ Events, UCLB News
On Tuesday 7 July 2015 UCLB hosted its Annual Summer Reception. The evening was set against the backdrop of the ...
UCLB spinout Chirp surpasses all expectations with successful crowdfunding campaign

UCLB spinout Chirp surpasses all expectations with successful crowdfunding campaign

/ Spinout News, UCLB News
Chirp, the award-winning sonic data transfer app incubated and hatched in UCL (University College London), closed its Crowdcube fundraising campaign ...
UCLB announces winners of the eighth annual UCL Awards for Enterprise

UCLB announces winners of the eighth annual UCL Awards for Enterprise

/ Award Winners, UCLB News
The UCL Business Award and the UCLB One to Watch Award came as part of the eighth annual UCL Awards ...
Golden shares and anti-dilution provisions in university spinouts

Golden shares and anti-dilution provisions in university spinouts

/ UCLB News
The Technology Transfer Offices (TTOs) of Cambridge, Edinburgh, Imperial, Oxford, Manchester and UCL have collaborated to produce another briefing paper ...
Abcodia appoints President of North America

Abcodia appoints President of North America

/ Spinout News
UCLB spinout company Abcodia, a specialist company engaged in the development of tests for early detection of cancer, today announced the ...
Endomag selected as finalist for top engineering award

Endomag selected as finalist for top engineering award

/ Spinout News
UCLB spinout company Endomag has been revealed as a finalist for the UK’s most prestigious engineering award. Endomag, which was shortlisted for its ...
Abcodia secures funding of £5.25 million ($8m) to launch the ROCA® test for the early detection of ovarian cancer

Abcodia secures funding of £5.25 million ($8m) to launch the ROCA® test for the early detection of ovarian cancer

/ Spinout News
Two new investors, Cambridge Innovative Capital and Scottish Equity Partners join existing investors Albion Ventures and UCLB The investment enables ...
MediaGamma secures seed funding for automated digital ad futures & options exchange

MediaGamma secures seed funding for automated digital ad futures & options exchange

/ UCLB News
MediaGamma, the first automatic futures and options exchange for digital advertising, today announced the closing of their seed round. The ...
Chirp is first UCL company to run a crowdfunding campaign (and hatches new products on the way)

Chirp is first UCL company to run a crowdfunding campaign (and hatches new products on the way)

/ Spinout News
UCL spinout Chirp, today announces a major platform upgrade and the launch of a crowdfunding campaign on CrowdCube. Devices ‘sing’ ...

Ovarian cancer blood tests breakthrough

/ UCLB News
A new screening method via a blood test for ovarian cancer has been found to detect twice as many cases ...
Six leading University TTOs issue briefing

Six leading University TTOs issue briefing

/ UCLB News
The Technology Transfer Offices of Edinburgh, Imperial, Oxford, Cambridge, Manchester and UCL have collaborated to produce a briefing paper, "UK ...
New treatment for cirrhosis, alcoholic and non-alcoholic fatty liver disease to be developed with an EU €6m grant at UCL

New treatment for cirrhosis, alcoholic and non-alcoholic fatty liver disease to be developed with an EU €6m grant at UCL

/ Spinout News
The Liver Failure Group, at the Institute for Liver and Digestive Health, UCL and the UCLB spinout, Yaqrit Limited, a ...
Two partners enter clinical development with biopharmaceuticals enabled by Abzena’s technology

Two partners enter clinical development with biopharmaceuticals enabled by Abzena’s technology

/ Spinout News
Abzena plc (AIM:ABZA), a spinout life sciences company from UCL School of Pharmacy, which provides services and technologies that enable the ...
UCL translational research incubator at Stevenage Bioscience Catalyst reaches capacity with addition of two new projects

UCL translational research incubator at Stevenage Bioscience Catalyst reaches capacity with addition of two new projects

/ UCLB News
UCL’s bioscience incubator at the Stevenage Bioscience Catalyst (SBC) has now reached capacity following the migration of two further research ...
Optimising UCL's contribution to medical innovation

Optimising UCL’s contribution to medical innovation

/ UCLB News
Professor Sir John Tooke, UCL Vice-Provost (Health) talks about optimising UCL's contribution to medical innovation; this includes how UCL can ...
How British women became doctors

How British women became doctors

/ UCLB News
In the lead up to International Women’s day, Professor McIntyre explains that Sophia Jex-Blake inspired him to write a book ...
UCLB and Cycle Pharmaceuticals enter into partnership to repurpose drugs for liver diseases

UCLB and Cycle Pharmaceuticals enter into partnership to repurpose drugs for liver diseases

/ UCLB News
UCLB is pleased to announce that it has entered into a partnership agreement with Cycle Pharmaceuticals to develop existing drugs for ...
Ipsen enters into option agreement to acquire Canbex Therapeutics

Ipsen enters into option agreement to acquire Canbex Therapeutics

/ Spinout News
Ipsen (Euronext: IPN; ADR: IPSEY) and Canbex Therapeutics Ltd (Canbex) today announced that Canbex has granted Ipsen an option giving ...
Appointment of new UCLB Chairman

Appointment of new UCLB Chairman

/ UCLB News
UCLB is pleased to announce the appointment of David Hunter as Chairman with effect from 20th January 2015. David Hunter ...
Spoonful of Sugar featured in The Telegraph online 

Spoonful of Sugar featured in The Telegraph online 

/ Spinout News, UCLB News
Spoonful of Sugar, a UCL School of Pharmacy spinout company supported by UCLB was today featured in The Telegraph online. Spoonful of Sugar ...
Clinically proven stretch mark prevention

Clinically proven stretch mark prevention

/ Spinout News, UCLB News
A solution to stretch marks that form during pregnancy is now available for purchase online. The unique three-part bump support ...
Syncona LLP and UCLB announce the formation of Autolus Limited, a cancer immunotherapy company

Syncona LLP and UCLB announce the formation of Autolus Limited, a cancer immunotherapy company

/ Spinout News, UCLB News
Syncona LLP (“Syncona”) and UCL Business PLC (“UCLB”), the wholly-owned technology transfer company of University College London (“UCL”), announce the ...
Six new approaches to fighting neurodegeneration to be funded in SBC's OI challenge

Six new approaches to fighting neurodegeneration to be funded in SBC’s OI challenge

/ Spinout News, UCLB News
Stevenage Bioscience Catalyst (SBC), the UK’s first open innovation bioscience campus, is delighted to announce that UCL was one of ...
UCL rated top UK university by research strength in the REF2014

UCL rated top UK university by research strength in the REF2014

/ UCLB News
Yesterday’s Research Excellence Framework 2014 (REF2014) results have rated UCL the top university in the UK for research strength. Included ...
First patient dosed in trial of novel T-cell therapy for leukaemia  Milestone for Cell Therapy Catapult, UCL Business & Imperial Innovations partnership

First patient dosed in trial of novel T-cell therapy for leukaemia Milestone for Cell Therapy Catapult, UCL Business & Imperial Innovations partnership

/ UCLB News
The first acute myeloid leukaemia patient has been dosed in a Phase I/ll cell therapy trial1 being undertaken by Catapult ...
UCLB SmartTarget® technology featured in the Mail online

UCLB SmartTarget® technology featured in the Mail online

/ Spinout News, UCLB News
SmartTarget® is an image fusion technology developed by a team led by Dr Dean Barratt of the Centre for Medical Image ...
Three new companies join Cancer Research UK-Abcodia collaboration

Three new companies join Cancer Research UK-Abcodia collaboration

/ Spinout News
Three new biomarker companies have been selected to work with the Early Diagnosis Consortium, a collaboration between Cancer Research UK, ...
Helicon Health and Inhealthcare join forces to improve stroke prevention

Helicon Health and Inhealthcare join forces to improve stroke prevention

/ Spinout News
Helicon Health is partnering with InHealthCare to deliver a step change in cardiac services in the NHS – making it easier for ...
UCL wi-fi innovation which can 'see' through walls wins NI Engineering Impact Award

UCL wi-fi innovation which can ‘see’ through walls wins NI Engineering Impact Award

/ UCLB News
A team of UCL researchers, assisted in commercialising their discovery by UCLB, have won the NI Engineering Impact Award for ...
Endomagnetics raises further investment to support US clinical trial, sales support and new product development

Endomagnetics raises further investment to support US clinical trial, sales support and new product development

/ Spinout News
Endomagnetics Ltd, the cancer healthcare spinout company from UCL , has raised a further £2m to support its pivotal US ...
OpSAFE exhibiting at Medica 2014

OpSAFE exhibiting at Medica 2014

/ Spinout News, UCLB News
UCLB  is pleased to announce that OpSAFE, a new CE marked plugin for touchless control of OsiriX MD will be ...
Chirp secures funding to develop vertical applications

Chirp secures funding to develop vertical applications

/ Spinout News, UCLB News
Asio Ltd, creator of Chirp, a technology and mobile app which allows devices to share data using snippets of sound, ...
Seven new ventures selected to join the first Health Social Innovators Programme in London

Seven new ventures selected to join the first Health Social Innovators Programme in London

/ Social Enterprise, UCLB News
Health Social Innovators, a pioneering accelerator programme for social ventures in health, launched last week with seven exciting ventures. The ...
Why universities are embracing social enterprise, from London to Chiang Mai

Why universities are embracing social enterprise, from London to Chiang Mai

/ Social Enterprise, UCLB News
In the Guardian online today, Ana Lemmo Charnalia, UCL Business’ Social Enterprise Business Manager talks about the engagement between universities ...
Touch-free medical image navigation

Touch-free medical image navigation

/ UCLB News
Surgeons often need to review X-ray or ultrasound images during a medical procedure. Currently, medical staff must either re-scrub after ...
Antitope and University College London enter into a Research & Licence Agreement for the generation of fully humanized antibodies using Antitope’s Composite Human Antibody™ technology

Antitope and University College London enter into a Research & Licence Agreement for the generation of fully humanized antibodies using Antitope’s Composite Human Antibody™ technology

/ Spinout News, UCLB News
Antitope Limited (Antitope), an Abzena (AIM: ABZA) company that provides services and technologies to enable the development of better biopharmaceuticals, ...
UCL Business in partnership with Healthbox and Numbers4Good launches search for early-stage health social ventures to benefit from Health Social Innovators’ Programme

UCL Business in partnership with Healthbox and Numbers4Good launches search for early-stage health social ventures to benefit from Health Social Innovators’ Programme

/ UCLB News
UCL Business and partners Healthbox, Numbers4Good, Trafford Housing Trust and Janssen Healthcare Innovation, have launched their search for early-stage social ...
UCLB supports annual research meeting between UCL, UWA and HMGU researchers

UCLB supports annual research meeting between UCL, UWA and HMGU researchers

/ UCLB News
This July UCL will host the UCL-UWA-HMGU Collaborative Research Network (CRN) annual meeting. This international collaboration brings together researchers from ...
Challenges and rewards of spinning out research

Challenges and rewards of spinning out research

/ Spinout News, UCLB News
BioVex, the company founded by former UCL Professor David S Latchman was sold to Amgen in 2011 for $1 billion; ...
Abzena plc, a UCL School of Pharmacy spinout company has raised £20 million in connection with forthcoming admission to AIM.

Abzena plc, a UCL School of Pharmacy spinout company has raised £20 million in connection with forthcoming admission to AIM.

/ Spinout News
Abzena, a revenue-generating life sciences company providing services and technologies that enable the development of better biopharmaceutical products, has conditionally ...
Annual UCLB Summer Reception

Annual UCLB Summer Reception

/ Events, UCLB News
On Tuesday 1 July 2014 UCLB hosted its Annual Summer Reception. The evening was set against the backdrop of the ...
Helicon Health cited in NICE guidelines

Helicon Health cited in NICE guidelines

/ Spinout News
Helicon Health’s web based package of services – HeliconHeart- is cited as an example of good practice in the new NICE ...
Chiesi Group and University College London announce partnership to develop a novel therapeutic for birth asphyxia

Chiesi Group and University College London announce partnership to develop a novel therapeutic for birth asphyxia

/ UCLB News
The Chiesi Group and UCL (University College London) are collaborating to test a novel melatonin formulation as a brain protective ...
UCLB signs exclusive licencing agreement with Collagen Solutions for next generation collagen products

UCLB signs exclusive licencing agreement with Collagen Solutions for next generation collagen products

/ Spinout News, UCLB News
UCL Business, the wholly-owned technology transfer company of UCL, has concluded an exclusive licencing agreement with Collagen Solutions – the ...
UCL Purification Technology Licensed to Puridify Receives £850,000 in Seed Funding

UCL Purification Technology Licensed to Puridify Receives £850,000 in Seed Funding

/ Spinout News, UCLB News
UCLB has invested in the next phase of development for Puridify, a newly formed company providing purification solutions for biotherapeutic ...
UCLB announces winners of the UCL Enterprise Awards for Enterprise

UCLB announces winners of the UCL Enterprise Awards for Enterprise

/ Award Winners, UCLB News
Professor Nathwani has been awarded the 2014 UCL Business Award for his work on Factor VIII gene therapy program for ...

Blood vessel research offers insights into new treatments for eye diseases

/ UCLB News
Leukaemia drugs could help to improve treatments for blindness caused by abnormal blood vessel growth in the eye, finds new ...
UCL, Imperial & Cell Therapy Catapult collaborate to advance leukaemia cell therapy

UCL, Imperial & Cell Therapy Catapult collaborate to advance leukaemia cell therapy

/ Spinout News, UCLB News
A novel cell therapy approach to the treatment of acute myeloid leukaemia is to be developed further via an innovative ...
UCL’s Resistive RAM (RRAM) featured in Research Media’s publication

UCL’s Resistive RAM (RRAM) featured in Research Media’s publication

/ Spinout News, UCLB News
Research on the next generation of memory devices based at UCL’s Department of Electrical and Electronic Engineering, has led to ...
Novozymes Biopharma to offer drug-albumin conjugation platform in collaboration with UCLB spinout ThioLogics

Novozymes Biopharma to offer drug-albumin conjugation platform in collaboration with UCLB spinout ThioLogics

/ Spinout News, UCLB News
ThioLogics, a UCL Business company, spun-out of the UCL Department of Chemistry has entered into a new collaboration with Novozymes ...
Team led by UCL & GOSH to develop infant oesophageal replacement product

Team led by UCL & GOSH to develop infant oesophageal replacement product

/ Spinout News, UCLB News
A team from UCL (University College London), Great Ormond Street Hospital (GOSH) and Royal Free Hospital is collaborating with the ...
Domainex programme shows great promise for the treatment of inflammatory diseases, such as chronic obstructive pulmonary disease (COPD).

Domainex programme shows great promise for the treatment of inflammatory diseases, such as chronic obstructive pulmonary disease (COPD).

/ Spinout News
UCLB spinout company Domainex Ltd. today announced that it has successfully completed a series of laboratory studies examining the in ...
Annual Report 2013/2014

Annual Report 2013/2014

/ Annual Reports
Download the 2013/2014 Annual Report pdf ...
UCLB signs exclusive global licence with BioKier Inc. for colonic delivery of gut hormone secretagogues for treatment of metabolic diseases including diabetes

UCLB signs exclusive global licence with BioKier Inc. for colonic delivery of gut hormone secretagogues for treatment of metabolic diseases including diabetes

/ Spinout News, UCLB News
UCLB has entered into an exclusive licence agreement with BioKier, Inc. for the proprietary colon delivery technology PhloralTM developed by ...
Endomagnetics wins business award for best new product

Endomagnetics wins business award for best new product

/ Spinout News
Endomagnetics Ltd, a UCLB spinout company that is developing a portfolio of products to improve the standard of breast cancer ...
Health Social Innovators’ Fund receives backing from Cabinet Office

Health Social Innovators’ Fund receives backing from Cabinet Office

/ Social Enterprise, UCLB News
The Cabinet Office has announced today that The Health Social Innovators’ Fund, a partnership between UCLB, Healthbox, Numbers4Good, Trafford Housing ...
UCL establishes its presence at Stevenage Bioscience Catalyst

UCL establishes its presence at Stevenage Bioscience Catalyst

/ Spinout News, UCLB News
UCL has established its presence in the Stevenage Bioscience Catalyst (SBC) through moving three research projects into laboratory space there ...
New innovation could mean eye injections are a thing of the past

New innovation could mean eye injections are a thing of the past

/ UCLB News
Drugs used to treat blindness-causing disorders could be successfully administered by eye drops rather than unpleasant and expensive eye injections, ...
UCLB’s online licensing system, e-lucid, goes live with first pilot customers

UCLB’s online licensing system, e-lucid, goes live with first pilot customers

/ UCLB News
E-lucid, an online system developed by UCLB to enable rapid licensing of software and materials arising from the UCL research base ...
Stem Cell transplants may restore sight to the blind

Stem Cell transplants may restore sight to the blind

/ UCLB News
Scientists at UCL have successfully extracted stem cells from the back of the eye and transplanted them into completely blind ...
Ocera Therapeutics starts patient enrollment in Phase IIb trial to treat HE patients

Ocera Therapeutics starts patient enrollment in Phase IIb trial to treat HE patients

/ Spinout News, UCLB News
Ocera Therapeutics last week announced the admission of its first patient in its multi-centre phase 2b, OCR-002 clinical trials. The ...
Helicon Health introduces its unique Stroke Prevention Package to David Willetts MP

Helicon Health introduces its unique Stroke Prevention Package to David Willetts MP

/ Spinout News
Helicon Health, an exciting growth business with a unique package of stroke prevention services, was one of only three companies ...
UCLB proud to support Slade Print Fair to benefit future Slade students

UCLB proud to support Slade Print Fair to benefit future Slade students

/ UCLB News
UCL’s Slade School of Fine Art, this week launched its inaugural Slade Print Fair. The print fair is a three ...

UCLB funded research wins prize in Roche Pharma Research & Early Development Oncology Awards

/ UCLB News
Vineeta Tripathi from the UCL Institute of Ophthalmology has won third prize in the first Roche Pharma Research & Early ...
UCLB signs MoU with University of Tartu  

UCLB signs MoU with University of Tartu  

/ UCLB News
A memorandum of understanding (MoU) has been signed between UCLB and the University of Tartu. The joint agreement will be ...
Abcodia’s CEO wins the 2013 prestigious WISE award for Enterprise and Innovation

Abcodia’s CEO wins the 2013 prestigious WISE award for Enterprise and Innovation

/ Spinout News
The 2013 prestigious WISE award for Enterprise and Innovation has been awarded to Dr Julie Barnes, CEO of UCLB spinout ...
Ocera Therapeutics announces $28 million private placement

Ocera Therapeutics announces $28 million private placement

/ Spinout News, UCLB News
In April 2009 Ocera Therapeutics, Inc. of San Diego, California licensed exclusive worldwide rights for the development and commercialisation of ...
Endomagnetics wins 2013 ETPN Nanomedicine Award

Endomagnetics wins 2013 ETPN Nanomedicine Award

/ Spinout News
Endomagnetics Ltd, the UCLB spinout company that is developing a portfolio of products to improve the standard of breast cancer ...
Canbex Therapeutics commences phase I clinical trial of lead product VSN16R as a potential treatment for spasticity in multiple sclerosis

Canbex Therapeutics commences phase I clinical trial of lead product VSN16R as a potential treatment for spasticity in multiple sclerosis

/ Spinout News, UCLB News
UCLB spinout company, Canbex Therapeutics Ltd announced today that it has commenced a Phase I clinical trial to assess the ...
UCL and Photobiotics partner in new approach to diagnose and treat gastric cancer

UCL and Photobiotics partner in new approach to diagnose and treat gastric cancer

/ UCLB News
An interdisciplinary research team from Photobiotics and UCL has been awarded £175,000 from the Technology Strategy Board’s (TSB) Biomedical Catalyst1 ...
UCLB spin-out Spirogen sold to AstraZeneca for $200 million

UCLB spin-out Spirogen sold to AstraZeneca for $200 million

/ Spinout News
Spirogen, a biotechnology company spun-out of UCL by UCL Business in 2001, has been sold to AstraZeneca. The company – ...
UCLB spinout company IXICO expands into Digital Healthcare

UCLB spinout company IXICO expands into Digital Healthcare

/ Spinout News
IXICO Limited, the medical image analysis company whose founders included Professors David Hawkes and Derek Hill from the Centre for ...
UCLB spinout company Abcodia continues to make impressive progress in the field of ovarian cancer screening.

UCLB spinout company Abcodia continues to make impressive progress in the field of ovarian cancer screening.

/ Spinout News, UCLB News
Recently receiving media attention, Abcodia is being recognised as an innovator in the discovery and verification of cancer screening. Collaborating ...
UCL adopts new humanitarian licensing policy to broaden access to essential medicines

UCL adopts new humanitarian licensing policy to broaden access to essential medicines

/ UCLB News
UCL makes public its policy, to make a commitment to promote the availability of healthcare-related technologies in developing countries and, through ...
Alive and Giving

Alive and Giving

/ Community
AliveandGiving.com an innovative charity fundraising website that promotes considered charitable giving. The website allows donors to search for, compare and ...
UCLB spinout brings birdsong to London Fashion Week

UCLB spinout brings birdsong to London Fashion Week

/ Spinout News
UCLB spinout, Chirp, has been selected by Topshop to incorporate its novel digital sharing technology into this autumn’s London Fashion Week ...
Canbex Therapeutics secures TSB Biocatalyst grant

Canbex Therapeutics secures TSB Biocatalyst grant

/ Spinout News
UCLB spinout company,  Canbex Therapeutics Ltd announced that it has secured a grant of £1.25M to further support the development ...
New treatment may work with folic acid to prevent neural tube defects like spina bifida

New treatment may work with folic acid to prevent neural tube defects like spina bifida

/ UCLB News
The recent publication by Professor Nicholas Greene and his colleagues at the UCL Institute of Child Health in the journal ...
Endomagnetics closes £2.1million series B funding round

Endomagnetics closes £2.1million series B funding round

/ Spinout News, UCLB News
Endomagnetics Ltd, the UCLB spinout company that is developing a portfolio of products to improve the standard of breast cancer ...
Expert Consortium awarded £2m to advance trachea replacement technology

Expert Consortium awarded £2m to advance trachea replacement technology

/ Spinout News, UCLB News
A tracheal replacement project, led by Videregen Ltd and involving a team of UK experts, has been awarded almost £2m ...
Scientists transplant photoreceptors from retina grown ‘in a dish’

Scientists transplant photoreceptors from retina grown ‘in a dish’

/ UCLB News
UCL scientists have carried out the first successful transplant of light-sensitive photoreceptor cells extracted from a synthetic retina, grown ‘in ...

Protein responsible for ‘bad’ blood vessel growth discovered

/ UCLB News
The discovery of a protein that encourages blood vessel growth, and especially ‘bad’ blood vessels – the kind that characterise ...
UCLB Licensee Linde launch Carbon Nanotube Ink

UCLB Licensee Linde launch Carbon Nanotube Ink

/ UCLB News
Linde Electronics, the global electronics business of The Linde Group, has launched SEERe- a revolutionary ink containing carbon nanotubes the ...
UCLB Annual Summer Reception

UCLB Annual Summer Reception

/ Events, UCLB News
On Tuesday 25th June 2013 UCLB hosted its Annual Summer Reception. The evening was set against the backdrop of the ...
Easy-to-use materials evaluation agreement

Easy-to-use materials evaluation agreement

/ UCLB News
UCLB, Isis Innovation Ltd and Imperial Innovations Group plc have together prepared a new easy-to-use agreement to help companies evaluate ...
Cost effective wireless sensor technology

Cost effective wireless sensor technology

/ Spinout News
UCLB spinout company, Senceive Ltd was recently interviewed by the Tunnelling Journal with the article showcasing how the company’s innovative ...
UCLB signs MoU with Kyoto University  

UCLB signs MoU with Kyoto University  

/ UCLB News
A memorandum of understanding has been signed between UCL (UCLB), Kyoto University (SACI) and its TLO organisation, the Kansai TLO ...
Amalyst Limited secures seed investment to commercialise a novel low cost electrocatalyst

Amalyst Limited secures seed investment to commercialise a novel low cost electrocatalyst

/ Spinout News, UCLB News
UCLB spin-out company, Amalyst Ltd, has completed a seed investment round to fund the commercialisation of a novel low cost ...
Rebecca Paulraj and her daughter Ria took part in the 5K RBC Race for Kids in aid of Great Ormond Street Hospital Charity

Rebecca Paulraj and her daughter Ria took part in the 5K RBC Race for Kids in aid of Great Ormond Street Hospital Charity

/ Community
UCLB is delighted to supported its staff members who raise money for charity. Rebecca Paulraj and her daughter Ria took part ...
Abcodia collaborates with Cancer Research UK to discover and develop tests for early diagnostics of cancer

Abcodia collaborates with Cancer Research UK to discover and develop tests for early diagnostics of cancer

/ Spinout News
UCLB spinout company, Abcodia is collaborating with Cancer Research UK and its commercial arm, Cancer Research Technology (CRT to develop ...
Avatar therapy helps silence voices in schizophrenia

Avatar therapy helps silence voices in schizophrenia

/ UCLB News
An avatar system that enables people with schizophrenia to control the voice of their hallucinations is being developed by researchers ...
Clinical Commissioning Groups sign up for new community-led stroke prevention service

Clinical Commissioning Groups sign up for new community-led stroke prevention service

/ Spinout News
New healthcare company, Helicon Health, has hit the ground running by securing commitment from four Clinical Commissioning Groups (CCGs) who ...
UCLB announces winners of the UCL Enterprise Awards for Enterprise

UCLB announces winners of the UCL Enterprise Awards for Enterprise

/ Award Winners, UCLB News
The UCL Business Award was presented to Professor Pete Coffey in recognition of his efforts with the London Project to ...
Canbex Therapeutics completes £2.1m financing round

Canbex Therapeutics completes £2.1m financing round

/ Spinout News, UCLB News
UCLB spinout company, Canbex Therapeutics Ltd has completed a £2.1m fundraising round that will enable the company to complete the ...
£47 million announced for innovation in healthcare

£47 million announced for innovation in healthcare

/ UCLB News
The Technology Strategy Board (TSB) and the Medical Research Council are to provide £47.2 million to UK businesses and universities, ...
Annual Report 2012/2013

Annual Report 2012/2013

/ Annual Reports
Download the UCLB Annual Report 2012_2013 pdf ...
UCLB launches new guide for translating university knowledge into Social Enterprise

UCLB launches new guide for translating university knowledge into Social Enterprise

/ UCLB News
Today sees the launch of a guide which seeks to assist staff in UK higher education institutions in transforming their ...
Annual Report 2011/2012

Annual Report 2011/2012

/ Annual Reports
Latest UCLB Annual Report is now available for download here: ...
Synthace is awarded a £500,000 TSB Synthetic Biology Grant

Synthace is awarded a £500,000 TSB Synthetic Biology Grant

/ Spinout News
UCLB spinout company,  Synthace Ltd, has been awarded funding from the Technology Strategy Board (TSB) for a collaborative project to ...
Endomagnetics Ltd secures strategic distribution agreement

Endomagnetics Ltd secures strategic distribution agreement

/ Spinout News, UCLB News
UCLB spinout company, Endomagnetics Ltd, is developing a portfolio of products to improve the standard of breast cancer management.Today, Endomagnetics ...
Domainex announces investment round to progress its TBK1/IKKe and epigenetic programmes

Domainex announces investment round to progress its TBK1/IKKe and epigenetic programmes

/ Spinout News, UCLB News
UCLB spinout company, Domainex Ltd has announced an investment round to raise £1.5m of capital. The first round was successful, ...
UCLB licences gene therapy program for haemophilia A to BioMarin

UCLB licences gene therapy program for haemophilia A to BioMarin

/ Spinout News, UCLB News
UCLB today announced that it has licensed a Factor VIII gene therapy program for haemophilia A to BioMarin Pharmaceuticals Inc ...
UCLB spinout company Senceive wins International Tunnelling Award

UCLB spinout company Senceive wins International Tunnelling Award

/ Spinout News
UCLB spinout company Senceive Ltd has won an International Tunnelling Award for joint work with Halcrow on the Bond Street ...
UCLB spinout company, Abcodia scoops four top startups awards

UCLB spinout company, Abcodia scoops four top startups awards

/ Spinout News, UCLB News
UCLB Spinout company, Abcodia swept the board at the  NatWest Startups Awards 2012 by scooping three top prizes, as well ...
Vince Cable launches Impact Acceleration Accounts at UCL spinout

Vince Cable launches Impact Acceleration Accounts at UCL spinout

/ Spinout News, UCLB News
Business secretary Vince Cable has launched a £60 million investment in UK universities during a visit to UCL spinout company ...
UCL spinout company, Abcodia named as finalist in the Startups Award 2012

UCL spinout company, Abcodia named as finalist in the Startups Award 2012

/ Spinout News, UCLB News
Abcodia, a UCL spin out company with investment from UCLB, has been shortlisted in three categories for the Startups Awards ...
New report showcases UCLB fuel cell technology

New report showcases UCLB fuel cell technology

/ Spinout News, UCLB News
A new report released by the Carbon Trust has outlined how five British organisations, including UCL researchers assisted by UCLB, ...
Dr Anne Lane ran the Royal Parks Foundation Half Marathon for Macmillan

Dr Anne Lane ran the Royal Parks Foundation Half Marathon for Macmillan

/ Community
UCLB is delighted to supported its staff members who raise money for charity. Dr Anne Lane ran the Royal Parks Foundation ...
UCLB is keen to support UCL student Entrepreneurs

UCLB is keen to support UCL student Entrepreneurs

/ Community
We have supported the UCLU Entrepreneur society with their ‘Apprentice’ style event and are currently working with their new president ...
UCLB signs exclusive global licence with Oxford Pharmascience

UCLB signs exclusive global licence with Oxford Pharmascience

/ Spinout News, UCLB News
UCLB signs exclusive global licence with Oxford Pharmascience for colonic delivery of statins UCLB  has entered into an exclusive licence ...
UCLB partners with HEFCE and UnLtd to offer more support to social entrepreneurs

UCLB partners with HEFCE and UnLtd to offer more support to social entrepreneurs

/ UCLB News
UCLB, along with UCL Advances, UCL’s centre for entrepreneurship and the UCLU Volunteering Services Unit, has been chosen to deliver ...
Wi-Fi innovation which can 'see' through walls

Wi-Fi innovation which can ‘see’ through walls

/ UCLB News
A team of UCL researchers, assisted in commercialising their discovery by UCLB, have discovered a revolutionary new way to detect ...
Olympic opening ceremony - creating the iconic map of London

Olympic opening ceremony – creating the iconic map of London

/ Spinout News, UCLB News
UCL spin out company, Space Syntax Ltd, has created the giant map of London’s street network which formed an iconic ...
New app 'Chirp' enables data sharing with sound

New app ‘Chirp’ enables data sharing with sound

/ Spinout News, UCLB News
UCL spinout Animal Systems has launched Chirp, a new application for iOS that lets you share pictures with sound. Originating ...
UCL Neuroscience Symposium

UCL Neuroscience Symposium

/ Community
UCLB has supported the UCL Neuroscience symposium for the past few years. The event attracts UCL researchers, partner NHS organisations (UCLH, ...
UCLB annual summer reception

UCLB annual summer reception

/ Events, UCLB News
On Tuesday 12th June 2012 UCLB hosted its Annual Summer Reception to celebrate a year of successes, with drinks, canapés ...
Drug licensed by UCLB shows strong potential through phase 2 clinical trials

Drug licensed by UCLB shows strong potential through phase 2 clinical trials

/ Spinout News, UCLB News
A drug developed at UCL and licenced by UCLB which aims to treat the effects of increased circulating ammonia levels ...
Novel process to mass produce graphene

Novel process to mass produce graphene

/ UCLB News
A team from UCL are working with UCLB to commercialise a radical new material – graphene. Professor Neal Skipper, Dr ...
Dr Rachel Hemsley completes 101 mile charity team bike ride for Bristol Rugby Community Foundation

Dr Rachel Hemsley completes 101 mile charity team bike ride for Bristol Rugby Community Foundation

/ Community
UCLB is delighted to supported its staff members who raise money for charity. Dr Rachel Hemsley rode the 101 mile charity ...
UCLB assists in development of an advanced memory concept

UCLB assists in development of an advanced memory concept

/ UCLB News
The first purely silicon oxide-based ‘Resistive RAM’ memory chip that can operate in ambient conditions – opening up the possibility ...
UCL Business Award Winners 2012

UCL Business Award Winners 2012

/ Award Winners
UCLB has announced the winners of two awards it has sponsored as part of the UCL Awards for Enterprise. Both ...
New humanised antibodies to treat cancer

New humanised antibodies to treat cancer

/ UCLB News
UCLB has been working closely with Professor Kerry Chester and her colleagues from the UCL Cancer Institute to support the ...
UCLB patented technology shows recovery of vision in glaucomatus rats

UCLB patented technology shows recovery of vision in glaucomatus rats

/ UCLB News
Scientists funded by the Medical Research Council have successfully used adult human retinal stem cells to repair nerve cells damaged ...
Endomagnetics wins a Life Sciences Award

Endomagnetics wins a Life Sciences Award

/ Spinout News
UCLB spinout company, Endomagnetics Wins a Life Sciences Award by the Science Business Innovation Board The award - given as ...
The Carbon Trust invests in UCLB novel low-cost fuel cell architecture

The Carbon Trust invests in UCLB novel low-cost fuel cell architecture

/ Spinout News
The Carbon Trust has invested in a novel, low-cost fuel cell architecture which is being commercialised by UCLB and Imperial ...
Abcodia collaborates with Volition Rx

Abcodia collaborates with Volition Rx

/ Spinout News, UCLB News
UCL spinout company, Abcodia collaborates with Volition Rx to advance the discovery of blood based biomarkers for cancer Abcodia, a ...
UCLB patented technology used to develop a potential new treatment for Corneal Surface Disease

UCLB patented technology used to develop a potential new treatment for Corneal Surface Disease

/ UCLB News
Researchers at UCL have made a significant advance towards developing a treatment for Corneal Surface Disease, using RAFTTM; a UCLB ...
UCLB supports venture capital firm MTI to target new investment fund

UCLB supports venture capital firm MTI to target new investment fund

/ UCLB News
The Orion fund is being launched in a partnership between UCLB, MTI and the technology transfer offices of the Universities ...
A team of budding student entrepreneurs have won a £500 cash prize, provided by UCLB, in the UCL Apprentice Challenge 2012.

A team of budding student entrepreneurs have won a £500 cash prize, provided by UCLB, in the UCL Apprentice Challenge 2012.

/ UCLB News
The competition, hosted by Ernst & Young at its London headquarters, saw the eight teams of students selected by the ...
Pentraxin Therapeutics founder is awarded a knighthood

Pentraxin Therapeutics founder is awarded a knighthood

/ Spinout News, UCLB News
UCLB 2011 Award winner, Professor Sir Mark Pepys was knighted for services to Biomedicine in this year's New Years Honour ...
UCL spinout company, Endomagnetics Ltd, has been shortlisted for the ACES final in 2012

UCL spinout company, Endomagnetics Ltd, has been shortlisted for the ACES final in 2012

/ Spinout News, UCLB News
The ACES (Academic Enterprise Awards) programme, formed to promote innovation in Europe, is holding its fourth annual awards final in ...

Gene therapy treatment of haemophilia

/ UCLB News
The recent publication by UCL (Professor Amit Nathwani), St Judes Children’s hospital and the Royal Free Hospital in the New ...
UCLB's consultant entrepreneur finishes top 30 in global entrepreneurship competition

UCLB’s consultant entrepreneur finishes top 30 in global entrepreneurship competition

/ Spinout News, UCLB News
Chester Mojay-Sinclare, UCLB's consultant entrepreneur and CEO of CharityCheckout.co.uk, participated in the 2011 Global Student Entrepreneurship Awards in New York, last month ...
UCLB agrees exclusive licence deal with the Linde Group

UCLB agrees exclusive licence deal with the Linde Group

/ Spinout News, UCLB News
UCLB has agreed an exclusive licence with the world-leading gases and engineering company The Linde Group for a process to ...
Cella Energy opens new facility at NASA's Kennedy Space Center

Cella Energy opens new facility at NASA’s Kennedy Space Center

/ Spinout News, UCLB News
Cella Energy Ltd is to set up a new facility at NASA's iconic Kennedy Space Center (NASA KSC) as a ...
UCLB’s antimicrobial catheter is featured in The Times

UCLB’s antimicrobial catheter is featured in The Times

/ UCLB News
The Times newspaper recently featured an article on UCLB’s patented antimicrobial catheter. The catheter, which will help to prevent infections ...
UCLB and the Survey of English Usage launch English Grammar App

UCLB and the Survey of English Usage launch English Grammar App

/ UCLB News
UCL Business PLC (UCLB) and The UCL Survey of English Usage (SEU) have launched an innovative iPhone App (the interactive Grammar of English, ...
UCLB helps to support the joint-UCL health research centres receive £165 million

UCLB helps to support the joint-UCL health research centres receive £165 million

/ UCLB News
UCLB, UCL’s technology transfer office has contributed to and supported and will continue to support the centres receiving the award ...
UCLB has agreed an exclusive licence with Periowave Dental Technologies

UCLB has agreed an exclusive licence with Periowave Dental Technologies

/ Spinout News, UCLB News
UCLB has agreed an exclusive licence for the disinfection and sterilisation of tissues, wounds and lesions in the oral cavity ...
UCLB supports the UCL Ear Institutes’ work with GSK spinout company Autifony

UCLB supports the UCL Ear Institutes’ work with GSK spinout company Autifony

/ Spinout News, UCLB News
The UCL Ear Institute, with support from UCLB, is delighted to be working with Autifony Therapeutics Limited (Autifony) to develop ...
UCLB spinout company, Endomagnetics Ltd secures funding for expansion and product launch

UCLB spinout company, Endomagnetics Ltd secures funding for expansion and product launch

/ Spinout News, UCLB News
UCLB spinout company Endomagnetics Ltd, whose magnetic sensing technology will extend the availability of best practice in cancer staging on a ...
UCLB and NCYPE announce a commercialisation agreement with special products limited for epistatus

UCLB and NCYPE announce a commercialisation agreement with special products limited for epistatus

/ Spinout News, UCLB News
UCL Business PLC (UCLB) and the National Centre for Young People with Epilepsy (NCYPE), a specialist epilepsy charity, have signed ...
UCLB annual summer reception

UCLB annual summer reception

/ Events, UCLB News
On Thursday 7 July UCLB hosted its annual Summer Reception to celebrate a year of successes, with drinks, canapés and ...
UCL technology used in windpipe transplant developed by UCLB

UCL technology used in windpipe transplant developed by UCLB

/ UCLB News
A UCL scientist and his team designed and built the synthetic windpipe 'scaffold' used in an operation in Sweden announced ...
UCL research team is presented with a commendation certificate at the prestigious Medical Futures event for their work on a UCLB patented technology

UCL research team is presented with a commendation certificate at the prestigious Medical Futures event for their work on a UCLB patented technology

/ UCLB News
UCL research team is presented with a commendation certificate at the prestigious Medical Futures event for their work on a ...
Launch of the UCL Electrochemical Innovation Lab

Launch of the UCL Electrochemical Innovation Lab

/ UCLB News
Electrochemical technology underpins many energy generation and environmentally friendly processes that can reduce CO2 emissions and improve global standards of living ...
UCLB’s consultant entrepreneur launches charity checkout

UCLB’s consultant entrepreneur launches charity checkout

/ Spinout News, UCLB News
UCL student and Consultant Entrepreneur at UCLB Chester Mojay-Sinclare has launched the Charity Checkout website, which offers a new payment service ...
UCLB and Albion Ventures jointly invest £1m in Abcodia

UCLB and Albion Ventures jointly invest £1m in Abcodia

/ Spinout News, UCLB News
Abcodia, a company engaged in the validation and discovery of molecular biomarkers for disease diagnosis and screening, is pleased to ...
Professor Mark Pepys wins UCLB 2011 Award

Professor Mark Pepys wins UCLB 2011 Award

/ UCLB News
UCLB awarded Professor Pepys the UCLB Award for 2011 at the UCL Enterprise Awards ceremony for his determination and perseverance ...
UCL Business Award Winners 2011

UCL Business Award Winners 2011

/ Award Winners
Professor Mark Pepeys UCLB awarded Professor Pepys the UCLB Award for 2011 at the UCL Enterprise Awards ceremony for his ...
UCLB’s novel phase-contrast X-ray technology featured in Nature

UCLB’s novel phase-contrast X-ray technology featured in Nature

/ UCLB News
Robert Speller, Alessandro Olivo and colleagues from the department of Medical Physics and Bioengineering at UCL have developed a novel ...
Catherine Sims runs the London Marathon

Catherine Sims runs the London Marathon

/ Community
UCLB is delighted to supported its staff members who raise money for charity. Catherine Sims ran the London Marathon in 2011 ...
Innovative UCLB idea scoops UK intellectual property office prize

Innovative UCLB idea scoops UK intellectual property office prize

/ Spinout News, UCLB News
The UK Intellectual Property Office (IPO) has announced UCL Business PLC (UCLB) as a winner of their Fast Forward 2011 ...
Annual Report 2010/2011

Annual Report 2010/2011

/ Annual Reports
Download the UCLB_Annual_Report2010_11 pdf ...
UCLB spin-out company, Canbex Therapeutics receives £1.75 million Translation Award from the Wellcome Trust

UCLB spin-out company, Canbex Therapeutics receives £1.75 million Translation Award from the Wellcome Trust

/ Spinout News
UCLB spin-out company, Canbex Therapeutics Ltd. (Canbex) announced today that it has received a Translation Award of up to £1.75 ...
UCLB & BD reach exclusive license agreement

UCLB & BD reach exclusive license agreement

/ Spinout News, UCLB News
UCL Business (UCLB), a wholly owned subsidiary of University College London (UCL), and BD (Becton, Dickinson and Company), a leading ...
Collaborative partners sought for Abcodia, a newly launched modular diagnostic company

Collaborative partners sought for Abcodia, a newly launched modular diagnostic company

/ Spinout News
Abcodia, an innovative company engaged in the validation and discovery of molecular biomarkers for disease diagnosis and screening, was formally ...
Cella Energy: a step closer to zero carbon emission

Cella Energy: a step closer to zero carbon emission

/ Spinout News
Cella Energy Ltd has been named the national winner of the 2011 Shell Springboard Awards for developing a novel hydrogen ...
UCL Professor Mark Pepys hailed as an ‘academic superstar’ by GlaxoSmithKline

UCL Professor Mark Pepys hailed as an ‘academic superstar’ by GlaxoSmithKline

/ Spinout News, UCLB News
As reported in the Financial Times today, GlaxoSmithKline (GSK) has announced it aims to sign up 10 academic ‘superstars’ for ...
Pentraxin announces licensing deal with GSK to develop medicine for rare disease

Pentraxin announces licensing deal with GSK to develop medicine for rare disease

/ Spinout News
University College London spin-out company Pentraxin Therapeutics Ltd has licensed a second drug development programme to pharmaceutical giant GlaxoSmithKline (GSK) ...
Spirogen Ltd., announces a research collaboration and licence agreement with Genentech

Spirogen Ltd., announces a research collaboration and licence agreement with Genentech

/ Spinout News
UCLB’s spin-out company, Spirogen Ltd., announces a research collaboration and licence agreement with Genentech for the discovery and development of ...
Endomagnetics cited as one of the UK’s ‘most promising healthcare technology businesses’

Endomagnetics cited as one of the UK’s ‘most promising healthcare technology businesses’

/ Spinout News
Endomagnetics Limited, the UCL spinout company pioneering the use of magnetic sensors for cancer staging and treatment, has recently been highlighted ...
UCLB highlighted as model for American universities in The Chronicle of Higher Education publication

UCLB highlighted as model for American universities in The Chronicle of Higher Education publication

/ UCLB News
UCL Business was covered in The Chronicle of Higher Education publication, ‘In Britain, a Tech-Transfer Operation Where Profits Aren't the ...
UCLB supports Imperial Innovations

UCLB supports Imperial Innovations

/ UCLB News
"Imperial Innovations, a leading technology commercialisation and investment group, has today announced that, it proposes raising up to £140 million ...
UCLB spin-out company, Biovex has been sold for $1 billion

UCLB spin-out company, Biovex has been sold for $1 billion

/ Spinout News
UCLB are delighted to announce that US biotechnology giant Amgen have brought Biovex, a cancer vaccine developer for $1 billion ...
Treatment for amyloidosis a step closer

Treatment for amyloidosis a step closer

/ Spinout News
UCL spin out company, Pentraxin Therapeutics Ltd, has hit the first milestone in its collaboration with pharmaceutical giant GlaxoSmithKline. Pentraxin ...
AstraZeneca and UCL join forces in sight-related stem cell medicine

AstraZeneca and UCL join forces in sight-related stem cell medicine

/ UCLB News
AstraZeneca and UCL have entered into a collaboration to develop regenerative medicines for diabetic retinopathy (DR). DR is now the ...
Endomagnetics announces investment and new CEO appointment

Endomagnetics announces investment and new CEO appointment

/ Spinout News
Endomagnetics Limited, the medical device company that helps surgeons to track the spread of breast cancer, has raised £770,000 from ...
Short courses for small companies and entrepreneurs

Short courses for small companies and entrepreneurs

/ Spinout News
Short Courses for Small Companies and Entrepreneurs Do you want to develop and refine key business and technical skills? Do ...
UCLB's summer reception

UCLB’s summer reception

/ Events, UCLB News
UCLB was delighted to host our annual Summer Reception on Thursday 22 July to celebrate a year of successes with ...
Official visit to Moorfields Eye Hospital by the new Health Minister

Official visit to Moorfields Eye Hospital by the new Health Minister

/ UCLB News
The newly appointed health minister, Earl Howe, chose to visit Moorfields Eye Hospital and the UCL Institute of Ophthalmology as ...
Groundbreaking 3D 2-photon microscope technology published by scientists at UCL

Groundbreaking 3D 2-photon microscope technology published by scientists at UCL

/ UCLB News
Scientists from the Department of Neuroscience, Physiology & Pharmacology at UCL have recently published details of their groundbreaking 3D 2-photon ...
Canbex Therapeutics Ltd receives new investment from Fast Forward

Canbex Therapeutics Ltd receives new investment from Fast Forward

/ Spinout News
Canbex Therapeutics Ltd and Fast Forward LLC are joining forces to develop VSN16R, an oral small molecule therapy with superior ...
UCL Business Award Winners 2010

UCL Business Award Winners 2010

/ Award Winners
Professor Quentin Pankhurst UCLB awarded  Professor Quentin Pankhurst the UCL Business Award for 2010  for his endeavours in the establishment ...
UCLB awards prizes at the first UCL Neuroscience Symposium

UCLB awards prizes at the first UCL Neuroscience Symposium

/ Award Winners, Events
UCLB were delighted to award prizes to winners of a poster competition at the first UCL Neuroscience Symposium. Prizes of £500, ...
UCLB marks the retirement of Professor Mike Spyer

UCLB marks the retirement of Professor Mike Spyer

/ UCLB News
After a long and successful career, UCLB is happy to wish Professor Mike Spyer the very best as he formally ...
EuroTempest features on 'The Naked Scientists' radio show

EuroTempest features on ‘The Naked Scientists’ radio show

/ Spinout News
EuroTempest Operations Director, Frank Roberts, speaks to Meera Senthilingam on how their weather forecasting software collects data and helps insurers ...
Annual Report 2009/2010

Annual Report 2009/2010

/ Annual Reports
Download the UCLB_Annual-Report_2009_2010 pdf ...
Elizabeth Highton, GB Fencing Team

Elizabeth Highton, GB Fencing Team

/ Community
Elizabeth is a full time student at UCL, she was voted UCLU’s Sports Person of the year and also earned ...
Novel imaging technology supported by Finance South East collaboration fund

Novel imaging technology supported by Finance South East collaboration fund

/ UCLB News
A scientist from UCL’s department of Medical Physics has received a major award from a new scheme to develop commercial ...
UCLB proof of concept funds help establish UCL drug target and screening facility

UCLB proof of concept funds help establish UCL drug target and screening facility

/ UCLB News
Jointly funded by UCLB and the Capital Infrastructure Fund (CIF), the recently established ChemiBank facility in the Wolfson Institute for ...
UCL scientists develop powerful new class of reagents for the modification of proteins

UCL scientists develop powerful new class of reagents for the modification of proteins

/ UCLB News
Scientists from the Department of Chemistry at UCL have recently published details of their ground-breaking technology to reversibly conjugate proteins ...
Domainex, secures funding from Takeda Research Investment

Domainex, secures funding from Takeda Research Investment

/ Spinout News
The biotechnology company Domainex has secured further financing to develop its Combinatorial Domain Hunting (CDH) technology, and to advance its ...
UCLB announces new partnership with Kurma Biofund

UCLB announces new partnership with Kurma Biofund

/ Spinout News, UCLB News
UCLB is delighted to announce a partnership with Kurma Biofund, a recently formed venture capital fund based in Paris and ...
Seeing a diagnosis: How an eye test could aid Alzheimer's detection

Seeing a diagnosis: How an eye test could aid Alzheimer’s detection

/ UCLB News
A simple and inexpensive eye test could aid detection and diagnosis of major neurological diseases such as Alzheimer’s at an ...
UCL spinout showcases pioneering device to breast cancer surgeons

UCL spinout showcases pioneering device to breast cancer surgeons

/ UCLB News
A UCL spinout company has given a global audience of surgeons and oncologists a glimpse of a pioneering breast cancer ...
New appointments to UCL's senior management team

New appointments to UCL’s senior management team

/ UCLB News
UCL President and Provost Professor Malcolm Grant today announced two new appointments to the university’s senior management team. Professor Stephen ...
Pfizer secures assets from Intercytex to support UCL collaborative research project

Pfizer secures assets from Intercytex to support UCL collaborative research project

/ UCLB News
Intercytex Group recently announced that it has completed the sale of certain assets related to stem cell therapies from its ...
UCL liver failure group present two studies at the American Association for Liver Disease

UCL liver failure group present two studies at the American Association for Liver Disease

/ Spinout News
The UCL Liver Failure Group presented data from two studies with OCR-002 (L-ornithine phenylacetate) to the annual American Association for ...
Call for applications for the UCL and J&J Proof of Concept fund

Call for applications for the UCL and J&J Proof of Concept fund

/ UCLB News
Johnson & Johnson and UCL have recently jointly established a co-managed £270,000 proof of concept fund. The fund will be managed ...
Investment in Endomagnetics Limited

Investment in Endomagnetics Limited

/ Spinout News, UCLB News
UCL Business PLC announces that it has led an initial investment round of £350,000 into Endomagnetics Limited, a spinout company ...
Emma Alam treks the Great Wall of China for Brain Tumour UK

Emma Alam treks the Great Wall of China for Brain Tumour UK

/ Community
UCLB is delighted to supported its staff members who raise money for charity. Emma Alam treked the Great Wall of China ...

£500,000 grant to develop synthetic artery

/ UCLB News
A team of researchers from UCL has won a £500,000 grant to develop a synthetic artery that mimics a natural ...
UCLB-branded graduated compression socks are premier league

UCLB-branded graduated compression socks are premier league

/ UCLB News
UCLB was delighted to support the UCL Advances recent “Future of Sport” event. Showcasing UCL’s contribution in this field the ...
UCLB hosts Summer Reception

UCLB hosts Summer Reception

/ Events, UCLB News
UCLB was delighted to host the annual Summer Reception event on 16th July to celebrate a year of successes with ...
UCL's cutting edge technologies get design to speed up route to market

UCL’s cutting edge technologies get design to speed up route to market

/ UCLB News
The Design Council has launched a new initiative using designers to help speed up the commercialisation of new technologies from ...
UCL Business supports the UCL Enterprise Awards 2009

UCL Business supports the UCL Enterprise Awards 2009

/ Award Winners, UCLB News
UCL Business and UCL Consultants were delighted to sponsor two key awards at the Enterprise Awards 2009 held on May ...
UCL global health research showcased in 'Better World Report'

UCL global health research showcased in ‘Better World Report’

/ Spinout News
Research from UCL features in the ‘2009 Better World Report’, which showcases examples of the most powerful research and technology ...
UCLB and Pfizer announce collaboration to advance development of Stem cell-based therapies

UCLB and Pfizer announce collaboration to advance development of Stem cell-based therapies

/ UCLB News
UCL Business PLC (UCLB) and Pfizer Regenerative Medicine today announced that they have entered into a collaboration and licence agreement focused ...
Alzheimer's disease: a new small molecule approach to treatment from University College London

Alzheimer’s disease: a new small molecule approach to treatment from University College London

/ Spinout News
New therapeutic approaches in Alzheimer’s disease are urgently needed. Work led by Professor Mark Pepys FRS over more than 20 ...
UCL partnership develops world-leading Virtual Exhibitions

UCL partnership develops world-leading Virtual Exhibitions

/ UCLB News
UCL has just signed three partnership agreements, which will enable the university to take a leading role in the development of ...
Annual Report 2008/2009

Annual Report 2008/2009

/ Annual Reports
Download the UCLB_Annual_Report_2008_2009 pdf ...
UCL and GSK join forces to develop combined small molecule-antibody treatment for rare disease

UCL and GSK join forces to develop combined small molecule-antibody treatment for rare disease

/ Spinout News, UCLB News
A collaboration to develop a world first drug-antibody dual treatment for the rare and often fatal condition amyloidosis has been ...
New alliance sees GlaxoSmithKline and Institute of Ophthalmology share compound research

New alliance sees GlaxoSmithKline and Institute of Ophthalmology share compound research

/ UCLB News
GlaxoSmithKline (GSK) and University College London’s Institute of Ophthalmology have entered into a three year strategic collaboration to investigate new ...
Pentraxin Therapeutics Ltd acquires full rights to develop a drug treatment in systemic amyloidosis

Pentraxin Therapeutics Ltd acquires full rights to develop a drug treatment in systemic amyloidosis

/ Spinout News, UCLB News
Pentraxin Therapeutics Ltd, has acquired the full rights to (R)-1-[6-[(R)-2-Carboxy-pyrrolidin-1-yl]-6-oxo-hexanoyl]pyrrolidine-2-carboxylic acid (CPHPC), a small molecule drug which targets serum amyloid ...
UCL Business announces a collaborative research programme with Axordia Ltd

UCL Business announces a collaborative research programme with Axordia Ltd

/ Spinout News, UCLB News
The London Project to Cure Blindness moves a step closer to achieving its aim as UCL Business announces the completion ...
Everywhere you go, always take the weather with you

Everywhere you go, always take the weather with you

/ Spinout News
Eurotempest Ltd and Tropical Storm Risk (TSR), both UCL projects in the Aon Benfield UCL Hazard Research Centre (ABUHRC) and ...
UCLB technology solutions for managing climate change

UCLB technology solutions for managing climate change

/ Spinout News
The UN Climate change Summit in Copenhagen is the biggest environmental meeting in history- so what is UCLB’s contribution? Dr ...
UCL Business wins 'Commercial Deal of the Year' award

UCL Business wins ‘Commercial Deal of the Year’ award

/ UCLB News
Following the sale of Stanmore Implants Worldwide Ltd (SIW) in February 2008 UCL Business PLC Managing Director, Mr Cengiz Tarhan ...
UCL Business supports development of innovative SnakeGrid software

UCL Business supports development of innovative SnakeGrid software

/ Spinout News, UCLB News
A local co-ordinates mapping solution developed by UCL’s Dr Jonathan Iliffe, Civil, Environmental & Geomatic Engineering, and awarded £9,500 proof ...
Novel polymer supported by UCLB wins business innovation award

Novel polymer supported by UCLB wins business innovation award

/ UCLB News
Alexander Seifalian, Professor of Nanotechnology and Regenerative Medicine and his research team received a Business Innovation Award in the Life ...
A radical approach for an HIV Vaccine

A radical approach for an HIV Vaccine

/ UCLB News
Using technology developed by Professor Benjamin Chain and patented by UCL Business, a team within UCL Immunology is conducting research ...
UCL Business concludes exclusive licence deal with Cerebricon

UCL Business concludes exclusive licence deal with Cerebricon

/ Spinout News, UCLB News
UCL Business is delighted to announce that Cerebricon Ltd, a pre-clinical contract research company that provides models of CNS disease ...
Grand Prix Winners and Record-Breakers - Lotus legends celebrate at UCL

Grand Prix Winners and Record-Breakers – Lotus legends celebrate at UCL

/ UCLB News
Legends from the world of motor racing and championship cars gathered at UCL on October 29th to celebrate the life ...
UCL Business brings future technology to genesis

UCL Business brings future technology to genesis

/ UCLB News
UCL Business is sponsoring a technology stream at the Genesis Conference, the seventh annual conference of the London Biotechnology Network, set ...
UCL leads key collaboration to enhance gene discovery findings in schizophrenia

UCL leads key collaboration to enhance gene discovery findings in schizophrenia

/ UCLB News
UCL has entered into a research collaboration to replicate the findings of a genome-wide association study carried out by Genizon ...
Globe Theatre hosts the London Project to Cure Blindness

Globe Theatre hosts the London Project to Cure Blindness

/ UCLB News
On the 16th January, visitors to the Globe Theatre had a chance to experience some of the daily difficulties faced ...
MRC grants £720,000.00 for UCL phase 1 study in hepatic encephalopathy

MRC grants £720,000.00 for UCL phase 1 study in hepatic encephalopathy

/ UCLB News
Further to key discoveries by Professor Rajiv Jalan and The Liver Failure Group at UCL, the Medical Research Council has awarded a grant ...
UCL biomedical breakthroughs draw crowds at genesis VII

UCL biomedical breakthroughs draw crowds at genesis VII

/ UCLB News
This year’s Genesis Conference witnessed a first-of-its-kind UCL Biomedical Innovation Showcase presenting a number of novel, life-changing technologies available for ...
UCL Business concludes an exclusive licence deal with Ondine

UCL Business concludes an exclusive licence deal with Ondine

/ Spinout News, UCLB News
Further to the news article on October 10th 2007 about Ondine and UCL's collaborative breakthrough Staphyloccocal Photodisinfection Technology, UCL Business is ...
UCL Business supports a marathon effort

UCL Business supports a marathon effort

/ UCLB News
UCL Business is delighted that two of its staff have put their best foot forward and scored a victory in ...
UCL Business supports the UCL Enterprise Awards 2008

UCL Business supports the UCL Enterprise Awards 2008

/ Award Winners, UCLB News
UCL Business and UCL Consultants were delighted to sponsor key awards at the UCL Enterprise Awards 2008 on May 1st.  ...
UCL Business concludes £multi-million sale of Stanmore Implants

UCL Business concludes £multi-million sale of Stanmore Implants

/ Spinout News, UCLB News
UCL Business has today announced the sale of Stanmore Implants Worldwide for around £10 million. The company, owned by UCL ...
UCL first major university in Europe to be available on Apple's iTunes U

UCL first major university in Europe to be available on Apple’s iTunes U

/ UCLB News
UCL Business is delighted to announce a landmark agreement with Apple Computer's iTunes service which will deliver a significant step ...
UCL biopharmaceutical spin-out, Domainex, secures £1million

UCL biopharmaceutical spin-out, Domainex, secures £1million

/ Spinout News
Domainex Ltd. (“Domainex”), an innovative biopharmaceutical company supported and marketed by UCL Business and spun-out from University College London, in ...
UCL is awarded £4m from the Wellcome Trust to fight Sepsis

UCL is awarded £4m from the Wellcome Trust to fight Sepsis

/ UCLB News
The Wellcome Trust has announced it will invest £4 million over three years from its Seeding Drug Discovery Initiative into ...
Technology Strategy Board funds Development of Novel Tissue Fabrication

Technology Strategy Board funds Development of Novel Tissue Fabrication

/ UCLB News
UCL Business is delighted to announce that breakthrough work coming from UCL's Tissue Repair and Engineering Centre at the Royal National Orthopaedic ...
The appliance of science

The appliance of science

/ UCLB News
Biotechnology is just one area where London’s universities are leading innovation by working alongside business. (From the Sunday Times, October ...
UCL Advances' first technology forum

UCL Advances’ first technology forum

/ UCLB News
'The Future of Imaging: Markets, Technology and Innovative Companies': UCL Advances hosted their first event on the 'Future of Imaging' ...
UCL Business spin-out Pentraxin Therapeutics awarded grant from the Wellcome Trust Seeding Drug Disc

UCL Business spin-out Pentraxin Therapeutics awarded grant from the Wellcome Trust Seeding Drug Disc

/ Spinout News, UCLB News
Professor Mark Pepys FRS FMedSci, a leading University College London (UCL) scientist, Head of Medicine at the Hampstead Campus (Royal ...
UCL Business takes to the grid at Formula Student 2007

UCL Business takes to the grid at Formula Student 2007

/ UCLB News
A team of mechanical engineering students from UCL, backed by UCL Business sponsorship, and led by senior lecturer Dr Kevin ...
Business sense from Universities, Prof. Mike Spyer

Business sense from Universities, Prof. Mike Spyer

/ UCLB News
UCL is London’s research powerhouse, with more than 3,500 academic and research staff in its science, technology, engineering and biomedical ...

Artificial artery that keeps your blood pumping

/ UCLB News
"A man-made artery that behaves just like the real thing could transform heart bypass surgery. The British invention looks like ...
Breakthrough clinical pathway software, developed by UCL and the Royal Free Hospital

Breakthrough clinical pathway software, developed by UCL and the Royal Free Hospital

/ UCLB News
In a ceremony in London on April 11th 2007, UCL and the Royal Free Hospital received a cheque for £4,086,000 ...
London Entrepreneur Challenge Awards inspires next generation of innovators

London Entrepreneur Challenge Awards inspires next generation of innovators

/ UCLB News
UCL hosted the UCL Enterprise Showcase, an event that marks the culmination of the London Entrepreneurs Challenge 07. The event ...
Novel 3D Colour Laser Scanner facility officially opened at UCL Chorley Institute

Novel 3D Colour Laser Scanner facility officially opened at UCL Chorley Institute

/ UCLB News
The latest generation, £500,000 Arius3D colour laser scanner, the first of its kind in Europe, was formally opened today at ...
UCL Business on top of the world!

UCL Business on top of the world!

/ UCLB News
UCL Business joined UCL’s medical team in Nepal to push scientific research to the absolute limit, ultimately carrying out experiments ...
UCL Business works closely with Professor Pete Coffey at the UCL Institute of Ophthalmology and Dire

UCL Business works closely with Professor Pete Coffey at the UCL Institute of Ophthalmology and Dire

/ UCLB News
The London Project to Cure AMD (Age-Related Macular Degeneration) will develop a surgical therapy to stabilise and restore vision in ...
UCL and Ondine Biopharma announce breakthrough staphyloccocal photodisinfection technology

UCL and Ondine Biopharma announce breakthrough staphyloccocal photodisinfection technology

/ Spinout News, UCLB News
UCL Business PLC, and Ondine Biopharma Corporation (TSX: OBP; AIM: OBP) today announced an important advance in photo-disinfection technology used ...
UCL enhances London Genetics' partnering capabilities

UCL enhances London Genetics’ partnering capabilities

/ UCLB News
Leading experts in genetics and genomics from UCL and six other academic institutions will provide insight into available expertise and ...
UCL work in Liver Disease wins MRC grant and industry partnership

UCL work in Liver Disease wins MRC grant and industry partnership

/ UCLB News
Innovative work into biomarkers for liver disease at UCL/UCLH has been recognized by the Medical Research Council, and has secured ...
UCL technology helps Space Syntax reveal human impact on urban planning

UCL technology helps Space Syntax reveal human impact on urban planning

/ Spinout News, UCLB News
UCL Business have successfully negotiated a renewal of Space Syntax’s licence of Depthmap, a unique software tool that allows the ...
New facility for testing orthopaedic treatments

New facility for testing orthopaedic treatments

/ UCLB News
The Stanmore Clinical Research Facility has opened, offering state-of-the-art clinical research facilities in a partnership between UCL Business and the ...
An answer to BBC calls for better testing of skin protection products

An answer to BBC calls for better testing of skin protection products

/ UCLB News
Following the BBC’s calls for accurate labeling and testing of skincare products, UCL Business is able to announce the first ...
Caudwell Xtreme Everest

Caudwell Xtreme Everest

/ Community
UCL Business joined UCL’s medical team in Nepal to push scientific research to the absolute limit, ultimately carrying out experiments ...